Suppr超能文献

[1310例热烧伤患者创面病原菌分布及耐药性分析]

[Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].

作者信息

Zhang C, Gong Y L, Luo X Q, Liu M X, Peng Y Z

机构信息

State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burn Research, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing 400038, China.

出版信息

Zhonghua Shao Shang Za Zhi. 2018 Nov 20;34(11):802-808. doi: 10.3760/cma.j.issn.1009-2587.2018.11.016.

Abstract

To analyze the distribution and drug resistance of pathogens from the wounds of thermal burn patients, so as to provide reliable basis for the rational use of antibiotics and the effective control over nosocomial infection. Wound samples of 1 310 thermal burn patients admitted into our burn wards from January 2012 to December 2017 were collected and retrospectively analyzed. API bacteria identification panels and automatical bacteria identification equipment were used to identify pathogens. E test was conducted to detect drug resistance of pathogens to vancomycin, tigecycline, and oxacillin. Kirby-Bauer paper disk diffusion method was used to detect drug resistance of pathogens to 31 antibiotics including penicillin G, gentamicin and rifampicin, etc., and drug resistance of fungi to 5 antifungal agents (voriconazole, amphotericin B, fluconazole, itraconazole, and ketoconazole). The WHONET 5.6 software was used to analyze the constituent ratios of Gram-negative bacteria, Gram-positive bacteria, and fungi in each year; the distribution of fungi; the distribution of top 10 bacteria with the highest constituent ratios in each year; the constituent ratios of methicillin-resistant (MRSA) and methicillin-sensitive (MSSA); the drug resistance of top 3 bacteria with the highest constituent ratios to commonly used antibiotics in each year; and the drug resistance of to commonly used antifungal agents. (1) Totally 2 183 strains of pathogens were isolated for the first time, including Gram-negative bacteria 1 194 (54.70%) strains, Gram-positive bacteria 879 (40.27%) strains, and fungi 110 (5.04%) strains. From 2012 to 2016, the constituent ratio of Gram-negative bacteria showed a decreasing trend, while that of Gram-positive bacteria showed an increasing trend year by year; and the constituent ratio of fungi was with a significantly increasing trend from 2016 to 2017. (2) Among all the fungi, the constituent ratio of ranked the first, ranked the second, and both ranked the third. (3) From 2012 to 2017, top 10 bacteria with the highest constituent ratios, from high to low, were and respectively. The constituent ratio of ranked the first in each year. The constituent ratio of was fluctuating but showed a rising trend comprehensively. The constituent ratio of went up after decreasing. (4) Among all the constituent ratio of MRSA was above 65.00%, while that of MSSA was below 31.00% in each year. (5) From 2012 to 2017, resistant to vancomycin, linezolid, or teicoplanin was not detected; the drug-resistant rates of MRSA to penicillin G, oxacillin, gentamicin, rifampicin, tetracycline, ciprofloxacin, ofloxacin, and levofloxacin were above or equal to 80.0% in each year; the drug-resistant rates of to clindamycin and erythrocin showed an obviously increasing trend, the drug-resistant rates of to moxifloxacin and queenoputin/daputin in 2017 were higher than those in 2016, while the drug-resistant rates of to the other 14 antibiotics showed no significant change in trend. From 2012 to 2017, was sensitive to polymyxin B and tigecycline; the drug-resistant rate of to ceftriaxone was relatively high; the drug-resistant rates of to levofloxacin, minocycline, and tetracycline were decreasing while those to the other 14 antibiotics went up after decreasing. From 2012 to 2017, wasn't resistant to polymyxin B, and its drug-resistant rates to the other 14 antibiotics showed decreasing trends. (6) The drug-resistant rates of to voriconazole, amphotericin B, fluconazole, itraconazole, and ketoconazole were all zero. The drug-resistant rates of non- to voriconazole, fluconazole, itraconazole, and ketoconazole were higher than those of . Among the pathogens from the wounds of thermal burn patients, and had the top 3 constituent ratios; the constituent ratio of non- was obviously higher than that of . The high drug resistance rates of and require more attention from clinicians and the local hospital's infection control department.

摘要

分析热烧伤患者创面病原菌的分布及耐药情况,为合理使用抗生素及有效控制医院感染提供可靠依据。收集2012年1月至2017年12月入住我院烧伤病房的1310例热烧伤患者的创面标本并进行回顾性分析。采用API细菌鉴定板及全自动细菌鉴定仪鉴定病原菌。采用E试验检测病原菌对万古霉素、替加环素及苯唑西林的耐药性。采用 Kirby-Bauer 纸片扩散法检测病原菌对青霉素G、庆大霉素、利福平等31种抗生素的耐药性以及真菌对5种抗真菌药物(伏立康唑、两性霉素B、氟康唑、伊曲康唑及酮康唑)的耐药性。应用WHONET 5.6软件分析每年革兰阴性菌、革兰阳性菌及真菌的构成比;真菌的分布情况;每年构成比最高的前10位细菌的分布情况;耐甲氧西林金黄色葡萄球菌(MRSA)及甲氧西林敏感金黄色葡萄球菌(MSSA)的构成比;每年构成比最高的前3位细菌对常用抗生素的耐药情况;真菌对常用抗真菌药物的耐药情况。(1)共首次分离出病原菌2183株,其中革兰阴性菌1194株(54.70%),革兰阳性菌879株(40.27%),真菌110株(5.04%)。2012年至2016年,革兰阴性菌构成比呈下降趋势,革兰阳性菌构成比逐年上升;2016年至2017年真菌构成比呈明显上升趋势。(2)在所有真菌中,构成比排名第一,排名第二,及并列排名第三。(3)2012年至2017年,构成比最高的前10位细菌依次为、。每年的构成比均排名第一。的构成比有波动但总体呈上升趋势。的构成比先下降后上升。(4)每年所有中,MRSA的构成比均高于65.00%,而MSSA的构成比均低于31.00%。(5)2012年至2017年,未检测到对万古霉素、利奈唑胺或替考拉宁耐药的;每年MRSA对青霉素G、苯唑西林、庆大霉素、利福平、四环素、环丙沙星、氧氟沙星及左氧氟沙星的耐药率均高于或等于80.0%;对克林霉素及红霉素的耐药率呈明显上升趋势,至莫西沙星及奎奴普丁/达福普丁的耐药率2017年高于2016年,而对其他14种抗生素的耐药率无明显变化趋势。2012年至2017年,对多黏菌素B及替加环素敏感;对头孢曲松的耐药率相对较高;对左氧氟沙星、米诺环素及四环素的耐药率呈下降趋势,而对其他14种抗生素的耐药率先下降后上升。2012年至2017年,对多黏菌素B不耐药,对其他14种抗生素的耐药率呈下降趋势。(6)对伏立康唑、两性霉素B、氟康唑、伊曲康唑及酮康唑的耐药率均为零。非对伏立康唑、氟康唑、伊曲康唑及酮康唑的耐药率高于。在热烧伤患者创面病原菌中,及的构成比位列前3;非的构成比明显高于。及较高的耐药率需临床医生及医院感染控制部门予以更多关注。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验